Saito Life Science Park (Saito LSP) is the most active Bio Cluster in Japan aiming at research and development in the biomedical field. It was born in April, 2004 on a greenery-rich hill about 18km away from Osaka central area.
Saito LSP aims to become the hub of the Northern Osaka Bio Cluster. Many pharmaceutical firms have traditionally concentrated in Osaka Dosho-machi area and a number of bio-medical research institutes including Osaka University are located in the surrounding of Saito LSP. This concentration bestows a unique advantage on Osaka. Saito LSP plans to promote research activity with this advantage and to activate this area through industry-university cooperation.
Saito LSP aims to become the hub of the Northern Osaka Bio Cluster. Many pharmaceutical firms have traditionally concentrated in Osaka Dosho-machi area and a number of bio-medical research institutes including Osaka University are located in the surrounding of Saito LSP. This concentration bestows a unique advantage on Osaka. Saito LSP plans to promote research activity with this advantage and to activate this area through industry-university cooperation.
2010-1-18
The Senri Life Science Seminar; "2010 Senri Life Science International Symposium on "Future Outcome of Stem Cell Research Today"
2009-11-27 (Monday) to 11-28
IPR Seminar: Signal transduction of active oxygen
2009-11-26
OBI Seminar; "Chemical synapses at atomic resolution: Structure and mechanism of transmitter-gated ion channels" by Dr.Eric Gouaux, Senior Scientist, Vollum Institute, Oregon Health and Science University
2009-11-6
The Senri Life Science Seminar; "The Next Generation of Brain Research"
2009-11-5
OBI Seminar; "Cilia dysfunction in syndromic and non-syndromic retinal degeneration" by Professor Anand Swaroop,Senior Investigator and Chief, Neurobiology-Neurodegeneration & Repair Laboratory,National Eye Institute,National Institutes of Health
2009-10-26
The 48th MTR Seminar "Cell and tissue culture design for the transplant --Technologies that cultivate and evaluate the cell and tissue-- " by Prof. Masahiro KINO-OKA (Dr. Eng.)(Associate Professor, Dept. of Orthopedic Surgery, Osaka City University Graduated School of Medicine)
2009-9-9
The 48th MTR Seminar "Reproduction of Articular Cartilage by the Cell Transplant- Mainly on the bone marrow mesenchymal cell (BMMC) transplantation" by Prof.Shigeyuki Wakitani (Dept. of Orthopedic Surgery, Osaka City University Graduated School of Medicine)
2009-8-25
The Senri Life Science Seminar; "Cancer Stem Cell Research Leading to Clinical Application"
2009-7-13 to 7-14
IPR Seminar: Clarification and control of Prion phenomenon based on its protein structures
2009-5-25
IFReC, The International Symposium; "Immune Regulation: Present and Future"
The Senri Life Science Seminar; "2010 Senri Life Science International Symposium on "Future Outcome of Stem Cell Research Today"
2009-11-27 (Monday) to 11-28
IPR Seminar: Signal transduction of active oxygen
2009-11-26
OBI Seminar; "Chemical synapses at atomic resolution: Structure and mechanism of transmitter-gated ion channels" by Dr.Eric Gouaux, Senior Scientist, Vollum Institute, Oregon Health and Science University
2009-11-6
The Senri Life Science Seminar; "The Next Generation of Brain Research"
2009-11-5
OBI Seminar; "Cilia dysfunction in syndromic and non-syndromic retinal degeneration" by Professor Anand Swaroop,Senior Investigator and Chief, Neurobiology-Neurodegeneration & Repair Laboratory,National Eye Institute,National Institutes of Health
2009-10-26
The 48th MTR Seminar "Cell and tissue culture design for the transplant --Technologies that cultivate and evaluate the cell and tissue-- " by Prof. Masahiro KINO-OKA (Dr. Eng.)(Associate Professor, Dept. of Orthopedic Surgery, Osaka City University Graduated School of Medicine)
2009-9-9
The 48th MTR Seminar "Reproduction of Articular Cartilage by the Cell Transplant- Mainly on the bone marrow mesenchymal cell (BMMC) transplantation" by Prof.Shigeyuki Wakitani (Dept. of Orthopedic Surgery, Osaka City University Graduated School of Medicine)
2009-8-25
The Senri Life Science Seminar; "Cancer Stem Cell Research Leading to Clinical Application"
2009-7-13 to 7-14
IPR Seminar: Clarification and control of Prion phenomenon based on its protein structures
2009-5-25
IFReC, The International Symposium; "Immune Regulation: Present and Future"
2009-10-22
A patent of new decoy oligonucleotides was concluded in Japan (chimera (double) decoys of NF-κB and ets)(2009-10-22)
2009-08-25
PROTEIN-MALL KANSAI
A coordinated project for the protein, "Protein Mall Kansai", was newly established on May 8, 2009, and many Saito LSP-located enterprises have been participating as active members.(2009-8-20)
2009-07-18
AnGes MG, Inc. announced that the project "Development of New Medical Supplies by Applying Functional Peptides with Reproduction Mechanism of Plant" (Joint R&D with Morishita Jintan Co., Ltd. and Osaka University) was adopted for METI's Grants.(2009-7-14)
2009-04-27
The 9th Bio-technology Business Competition JAPAN highest award and
outstanding prize were decided.(2009-3-16)
2009-01-28
Kringle Pharma,Inc. is proud to announce that the clinical trial application of ChronSealR®
to the Swedish authority, Medical Products Agency (MPA),
dated 23 December 2008 was approved on 23 January 2009. Having its approval granted by the authority, KRINGLE will conduct a phase I/II clinical trial of ChronSealR® in Sweden.
2009-01-09
Toyopolymer.Co,.Ltd. announced that new material "RUBYLER" for the prosthetic limb has developed. "RUBYLER" is more lightweight and less stuffiness than any other breathable prosthetic material (artificial limb), then it will be exhibited to Convertech Japan2009 (2/18-20 Tokyo).
A patent of new decoy oligonucleotides was concluded in Japan (chimera (double) decoys of NF-κB and ets)(2009-10-22)
2009-08-25
PROTEIN-MALL KANSAI
A coordinated project for the protein, "Protein Mall Kansai", was newly established on May 8, 2009, and many Saito LSP-located enterprises have been participating as active members.(2009-8-20)
2009-07-18
AnGes MG, Inc. announced that the project "Development of New Medical Supplies by Applying Functional Peptides with Reproduction Mechanism of Plant" (Joint R&D with Morishita Jintan Co., Ltd. and Osaka University) was adopted for METI's Grants.(2009-7-14)
2009-04-27
The 9th Bio-technology Business Competition JAPAN highest award and
outstanding prize were decided.(2009-3-16)2009-01-28
Kringle Pharma,Inc. is proud to announce that the clinical trial application of ChronSealR®
to the Swedish authority, Medical Products Agency (MPA),
dated 23 December 2008 was approved on 23 January 2009. Having its approval granted by the authority, KRINGLE will conduct a phase I/II clinical trial of ChronSealR® in Sweden.
2009-01-09
Toyopolymer.Co,.Ltd. announced that new material "RUBYLER" for the prosthetic limb has developed. "RUBYLER" is more lightweight and less stuffiness than any other breathable prosthetic material (artificial limb), then it will be exhibited to Convertech Japan2009 (2/18-20 Tokyo).
The objective of the Promotion Council is to contribute to the promotion of the construction of "Saito" by conducting research and studies and developing plans and proposals for an amenity-rich and integrated metropolis where its urban functions are in harmony with the natural surroundings.